// App-Quantinova.ai

468.0 : Determinants of first-line treatment selection in advanced pancreatic ductal adenocarcinoma (PDAC).

Researchers

Presenter

  • Hui-Li Wong

Principal Investigators

  • Ying Wang

  • Yaling Yin

  • Hagen F. Kennecke

  • Winson Y. Cheung

  • Daniel John Renouf

  • Sharlene Gill

Medical Centers

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Gastrointestinal Cancer Outcomes Institute, BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Carbohydrate antigen 19-9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved